Dynavax Technologies (NASDAQ:DVAX)‘s stock had its Buy rating Reiterated by analysts at HC Wainwright in a research report issued to clients and investors. A price-to-earnings ratio of #N/A, market cap of 693.9M and a beta of 1.15.  Dynavax Technologies has a twelve month low $1.80 of  and a twelve month high of $8.12.

Shares of Dynavax Technologies traded up $0.40 on Friday, reaching $6.54. 10698287 shares of the stock traded hands, compared to its average volume of 8352476. Shares of Dynavax Technologies at end of the day on Friday were at $6.54. The firm’s 50 day moving average is $$4.85 and its 200 day moving average is $4.85.Dynavax Technologies  has a 12 month low of $6.35 and a 12 month high of $8.12. While on yearly highs and lows, Dynavax Technologies’s today has traded high as $7.07 and has touched $6.35 on the downward trend. See More Analyst Rating at: RATING

Dynavax Technologies (NASDAQ:DVAX) Moving Average Technical Analysis

5 day Moving Average is $6.25 And 5 day price change is $0.82 (14.45%)  with average volume for 5 day average is 5,404,280. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $6.05 and 20 day price change is $0.88 (15.46%) and average 20 day moving volume is 8,715,380. 50 day moving average is $4.85  and 50 day price change is $3.38 ( 107.46%)  and with average volume for 50 days is : 6,332,472. 200 day moving average is $4.85  and 200 day price change is $1.91 (41.45%)  and with average volume for 200 days is : 2,604,454.

See More Analyst Rating at: RATING

Dynavax Technologies Earnings and What to expect: 

Earnings for Dynavax Technologies are expected to grow in the coming year, from ($1.06) to ($0.48) per share. The P/E ratio of Dynavax Technologies is -3.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Dynavax Technologies is -3.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Dynavax Technologies has a P/B Ratio of 65.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 13.33%
  • On 5/27/2020 Director Andrew A F Hack Buy 1,000,000 at average share price of $4.84 which equates to $4,840,000.00 in money value.
  • On 5/19/2020 SVP Robert Janssen Sell 15,000 at average price of  $6.33 with total value of : Not Data Available
  • On 5/5/2020 SVP Robert Janssen Sell 9,000 at average price of  $4.43 with total value of : $39,870.00

What other brokers have to say about Dynavax Technologies :

  • 6/15/2020 – Dynavax Technologies is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $14.00 price target on the stock.
  • 6/11/2020 – Dynavax Technologies was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 6/5/2020 – Dynavax Technologies was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating.
  • 6/4/2020 – Dynavax Technologies was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $7.75 price target on the stock.

Other firm’s rating by HC Wainwright:

  • 6/19/2020 – Sierra Metals had its “buy” rating re-affirmed by analysts at HC Wainwright. They now have a $2.25 price target on the stock.
  • 6/19/2020 – McEwen Mining had its “buy” rating re-affirmed by analysts at HC Wainwright. They now have a $1.75 price target on the stock.
  • 6/19/2020 – HTG Molecular Diagnostics had its “buy” rating re-affirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock.
  • 6/19/2020 – Taro Pharmaceutical Industries had its “buy” rating re-affirmed by analysts at HC Wainwright. They now have a $96.00 price target on the stock.

See More Analyst Rating at: RATING



Source link